IGC Pharma, Inc. IGC
0.20 USD +0.01 (+4.84%)
At closeNov 5, 2026, 7:00 AM EST
0.20 +0.01 +3.08%
Pre-market · Nov 5, 7:00 AM ET
0.1876 Day range 0.195
0.08 52-week range 0.40
- YTD
- -30.36%
- 1 year
- -50.00%
Revenue & Expenses
Latest period ending Mar 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|
| 1.27M | 1.34M | 911.00K | 397.00K | 898.00K | |
| 619.00K | 733.00K | 442.00K | 194.00K | 113.00K | |
| -7.45M | -9.80M | -11.57M | -15.43M | -8.72M | |
| -7.12M | -13.00M | -11.51M | -15.02M | -8.81M | |
| -0.09 | -0.22 | -0.22 | -0.30 | -0.21 |
Balance sheet
| Fiscal year | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|
| 800.00K | 1.41M | 3.55M | 11.44M | 17.78M | |
| 8.75M | 9.90M | 17.18M | 26.83M | 35.87M | |
| 2.42M | 2.58M | 2.27M | 2.94M | 3.06M | |
| 144.00K | 221.00K | 348.00K | 485.00K | 985.00K | |
| 6.33M | 7.32M | 14.91M | 23.89M | 32.80M |
Cash flow
| Fiscal year | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|
| -4.79M | -5.20M | -7.05M | -7.46M | -10.80M | |
| -442.00K | -317.00K | -235.00K | -742.00K | 3.39M | |
| 4.45M | 3.52M | 100.00K | 4.14M | 14.69M | |
| -72.00K | -94.00K | 228.00K | -207.00K | -1.47M | |
| -793.00K | -2.00M | -7.26M | -4.09M | 7.29M |